International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8080590
Original Article
Comparison of Phq2 and Phq9 As A Screening Tool for Depression in Adolescents Admitted to Tertiary Care Centre
 ,
Published
June 26, 2023
Abstract

Background: Depression is a significant concern in adolescents, especially in hospitalized patients. Efficient screening tools are critical to detect and manage depression in this population. This study aimed to compare the predictive value of PHQ2 and PHQ9 scores in detecting depression in adolescents in a tertiary care hospital setting.

Methods: A prospective cohort study was conducted involving 70 adolescent patients (aged 10-19 years) admitted in Bangalore Medical College and Research Institute hospitals from March to April 2023. Patients were assessed using PHQ2 and PHQ9 questionnaires during their hospital stay.

Results: Results demonstrated a strong positive correlation between PHQ2 and PHQ9 scores (r=0.852, p<0.01). Out of the total patients, 25.7% scored ≥3 on PHQ2, indicating a risk for depression. PHQ9 categories ranged from Minimal to Severe Depression, with 60.0% of participants falling under Minimal Depression and 14.3% under Mild to Severe Depression categories.

Conclusion: The study confirms the efficacy of both PHQ2 and PHQ9 as reliable screening tools for depression among adolescents in a tertiary care setting. Both tools are advantageous, with PHQ2 offering a rapid initial assessment and PHQ9 providing a detailed evaluation of depression severity. These findings underscore the importance of routine mental health screenings in hospitals.

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
220 Views
266 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved